These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27639260)

  • 1. A Population Pharmacokinetic Model for Vancomycin in Adult Patients Receiving Extracorporeal Membrane Oxygenation Therapy.
    Moore JN; Healy JR; Thoma BN; Peahota MM; Ahamadi M; Schmidt L; Cavarocchi NC; Kraft WK
    CPT Pharmacometrics Syst Pharmacol; 2016 Sep; 5(9):495-502. PubMed ID: 27639260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of venovenous extracorporeal membrane oxygenation on pharmacokinetics of vancomycin in lung transplant recipients.
    Liu D; Chen W; Wang Q; Li M; Zhang Z; Cui G; Li P; Zhang X; Ma Y; Zhan Q; Wang C
    J Clin Pharm Ther; 2020 Oct; 45(5):1066-1075. PubMed ID: 32542736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of vancomycin in patients receiving extracorporeal membrane oxygenation.
    Mulla H; Pooboni S
    Br J Clin Pharmacol; 2005 Sep; 60(3):265-75. PubMed ID: 16120065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of vancomycin in adults receiving extracorporeal membrane oxygenation.
    Wu CC; Shen LJ; Hsu LF; Ko WJ; Wu FL
    J Formos Med Assoc; 2016 Jul; 115(7):560-70. PubMed ID: 26123638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study.
    Shekar K; Fraser JF; Taccone FS; Welch S; Wallis SC; Mullany DV; Lipman J; Roberts JA;
    Crit Care; 2014 Dec; 18(6):565. PubMed ID: 25636084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin population pharmacokinetics during extracorporeal membrane oxygenation therapy: a matched cohort study.
    Donadello K; Roberts JA; Cristallini S; Beumier M; Shekar K; Jacobs F; Belhaj A; Vincent JL; de Backer D; Taccone FS
    Crit Care; 2014 Nov; 18(6):632. PubMed ID: 25416535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of intravenous sufentanil in critically ill patients supported with extracorporeal membrane oxygenation therapy.
    Hahn J; Yang S; Min KL; Kim D; Jin BH; Park C; Park MS; Wi J; Chang MJ
    Crit Care; 2019 Jul; 23(1):248. PubMed ID: 31288863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Neonates on Extracorporeal Life Support.
    Cies JJ; Moore WS; Nichols K; Knoderer CA; Carella DM; Chopra A
    Pediatr Crit Care Med; 2017 Oct; 18(10):977-985. PubMed ID: 28650363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin pharmacokinetics in neonates receiving extracorporeal membrane oxygenation.
    Buck ML
    Pharmacotherapy; 1998; 18(5):1082-6. PubMed ID: 9758319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation.
    Amaker RD; DiPiro JT; Bhatia J
    Antimicrob Agents Chemother; 1996 May; 40(5):1139-42. PubMed ID: 8723454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population Pharmacokinetics and Dose Optimization of Teicoplanin during Venoarterial Extracorporeal Membrane Oxygenation.
    Wi J; Noh H; Min KL; Yang S; Jin BH; Hahn J; Bae SK; Kim J; Park MS; Choi D; Chang MJ
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trough Concentrations of Vancomycin in Patients Undergoing Extracorporeal Membrane Oxygenation.
    Park SJ; Yang JH; Park HJ; In YW; Lee YM; Cho YH; Chung CR; Park CM; Jeon K; Suh GY
    PLoS One; 2015; 10(11):e0141016. PubMed ID: 26544074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic Assessment of Pre- and Post-Oxygenator Vancomycin Concentrations in Extracorporeal Membrane Oxygenation: A Prospective Observational Study.
    Mahmoud AA; Avedissian SN; Al-Qamari A; Bohling T; Pham M; Scheetz MH
    Clin Pharmacokinet; 2020 Dec; 59(12):1575-1587. PubMed ID: 32468446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population Pharmacokinetics of Vancomycin in Pediatric Extracorporeal Membrane Oxygenation.
    Moffett BS; Morris J; Galati M; Munoz F; Arikan AA
    Pediatr Crit Care Med; 2018 Oct; 19(10):973-980. PubMed ID: 30063652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population Pharmacokinetics of Vancomycin in Critically Ill Adult Patients Receiving Extracorporeal Membrane Oxygenation (an ASAP ECMO Study).
    Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Cho YJ; Corley A; Diehl A; Gilder E; Jakob SM; Kim HS; Levkovich BJ; Lim SY; McGuinness S; Parke R; Pellegrino V; Que YA; Reynolds C; Rudham S; Wallis SC; Welch SA; Zacharias D; Fraser JF; Shekar K; Roberts JA;
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0137721. PubMed ID: 34633852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose Optimization of Cefpirome Based on Population Pharmacokinetics and Target Attainment during Extracorporeal Membrane Oxygenation.
    Kang S; Jang JY; Hahn J; Kim D; Lee JY; Min KL; Yang S; Wi J; Chang MJ
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32122899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective Cohort Study of Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Adults on Extracorporeal Membrane Oxygenation.
    Jung Y; Lee DH; Kim HS
    Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33257444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients.
    Hahn J; Choi JH; Chang MJ
    J Clin Pharm Ther; 2017 Dec; 42(6):661-671. PubMed ID: 28948652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Extracorporeal Membrane Oxygenation on the New Vancomycin Dosing Regimen in Critically Ill Patients Receiving Continuous Venovenous Hemofiltration.
    Yang CJ; Wu CW; Wu CC
    Ther Drug Monit; 2018 Jun; 40(3):310-314. PubMed ID: 29746432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population Pharmacokinetic Model for Vancomycin Used in Open Heart Surgery: Model-Based Evaluation of Standard Dosing Regimens.
    Alqahtani SA; Alsultan AS; Alqattan HM; Eldemerdash A; Albacker TB
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29686154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.